应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
NKTX Nkarta
盘后交易 03-28 16:50:40 EDT
10.81
-0.27
-2.48%
盘后
11.20
+0.39
+3.61%
16:49 EDT
最高
11.37
最低
10.59
成交量
118.82万
今开
10.80
昨收
11.09
日振幅
7.04%
总市值
7.59亿
流通市值
2.78亿
总股本
7,019万
成交额
1,291万
换手率
4.61%
流通股本
2,575万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
Nkarta, Inc.盘中异动 大幅拉升5.07%
自选股智能写手 · 03-27 21:47
Nkarta, Inc.盘中异动 大幅拉升5.07%
Nkarta, Inc.盘中异动 快速拉升5.00%
自选股智能写手 · 03-26 21:32
Nkarta, Inc.盘中异动 快速拉升5.00%
Nkarta, Inc.盘中异动 股价大涨25.29%
自选股智能写手 · 03-25
Nkarta, Inc.盘中异动 股价大涨25.29%
BUZZ-Nkarta公司放弃血癌疗法开发后业绩下滑
Reuters · 03-22
BUZZ-Nkarta公司放弃血癌疗法开发后业绩下滑
Nkarta, Inc.盘中异动 股价大跌26.81%
自选股智能写手 · 03-22
Nkarta, Inc.盘中异动 股价大跌26.81%
Nkarta Inc盘中异动 早盘快速下挫5.04%
自选股智能写手 · 02-21
Nkarta Inc盘中异动 早盘快速下挫5.04%
加载更多
公司概况
公司名称:
Nkarta
所属市场:
NASDAQ
上市日期:
--
主营业务:
Nkarta, Inc.于2015年7月在特拉华州成立。该公司是一家私人生物制药公司,致力于开发工程化的自然杀伤(NK)细胞来对抗癌症。该公司致力于利用NK细胞的天然强大功能来识别和杀死异常细胞,并募集适应性免疫效应子以产生特异性和持久性的反应。
发行价格:
--
{"stockData":{"symbol":"NKTX","market":"US","secType":"STK","nameCN":"Nkarta","latestPrice":10.81,"timestamp":1711656000000,"preClose":11.085,"halted":0,"volume":1188225,"hourTrading":{"tag":"盘后","latestPrice":11.2,"preClose":10.81,"latestTime":"16:49 EDT","volume":11808,"amount":127989.74592,"timestamp":1711658965859},"delay":0,"floatShares":25752433,"shares":70191295,"eps":-2.397279,"marketStatus":"盘后交易","marketStatusCode":4,"change":-0.275,"latestTime":"03-28 16:50:40 EDT","open":10.8,"high":11.37,"low":10.59,"amount":12907779.668325001,"amplitude":0.070365,"askPrice":11.42,"askSize":9990,"bidPrice":11.25,"bidSize":2088,"shortable":3,"etf":0,"ttmEps":-2.397279,"exchange":"NASDAQ","tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1711670400000},"adr":0,"listingDate":1594353600000,"adjPreClose":11.085,"preHourTrading":{"tag":"盘前","latestPrice":10.9,"preClose":11.085,"latestTime":"09:25 EDT","volume":1429,"amount":15746.992681,"timestamp":1711632300060},"postHourTrading":{"tag":"盘后","latestPrice":11.2,"preClose":10.81,"latestTime":"16:49 EDT","volume":11808,"amount":127989.74592,"timestamp":1711658965859},"volumeRatio":0.438513},"requestUrl":"/m/hq/s/NKTX","defaultTab":"news","newsList":[{"id":"2422291894","title":"Nkarta, Inc.盘中异动 大幅拉升5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2422291894","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2422291894?lang=zh_cn&edition=full","pubTime":"2024-03-27 21:47","pubTimestamp":1711547258,"startTime":"0","endTime":"0","summary":"北京时间2024年03月27日21时47分,Nkarta, Inc.股票出现波动,股价急速拉升5.07%。截至发稿,该股报10.37美元/股,成交量17.0357万股,换手率0.24%,振幅5.42%。Nkarta, Inc.股票所在的生物技术行业中,整体涨幅为0.09%。Nkarta, Inc.公司简介:Nkarta Inc 是一家生物制药公司,致力于开发用于治疗癌症的工程化自然杀伤 细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240327214738791d4bf1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240327214738791d4bf1&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422613134","title":"Nkarta, Inc.盘中异动 快速拉升5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2422613134","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2422613134?lang=zh_cn&edition=full","pubTime":"2024-03-26 21:32","pubTimestamp":1711459941,"startTime":"0","endTime":"0","summary":"北京时间2024年03月26日21时32分,Nkarta, Inc.股票出现异动,股价快速拉升5.00%。Nkarta, Inc.股票所在的生物技术行业中,整体涨幅为0.33%。其相关个股中,Stoke Therapeutics, Inc.、180 Life Sciences Corp C/Wts 07/11/2025、Abvc Biopharma, Inc.涨幅较大,Abvc Biopharma, Inc.、Xtl生物制药、Stoke Therapeutics, Inc.较为活跃,换手率分别为99.46%、11.05%、10.02%,振幅较大的相关个股有Stoke Therapeutics, Inc.、Molecular Templates, Inc.、Sellas Life Sciences Group, Inc.,振幅分别为24.77%、14.64%、9.62%。Nkarta, Inc.公司简介:Nkarta Inc 是一家生物制药公司,致力于开发用于治疗癌症的工程化自然杀伤 细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403262132217a4f3429&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403262132217a4f3429&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422195548","title":"Nkarta, Inc.盘中异动 股价大涨25.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2422195548","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2422195548?lang=zh_cn&edition=full","pubTime":"2024-03-25 21:31","pubTimestamp":1711373503,"startTime":"0","endTime":"0","summary":"北京时间2024年03月25日21时31分,Nkarta, Inc.股票出现异动,股价急速上涨25.29%。Nkarta, Inc.股票所在的生物技术行业中,整体跌幅为0.52%。其相关个股中,Landos Biopharma, Inc.、Altamira Therapeutics Ltd.、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大,Altamira Therapeutics Ltd.、Salarius Pharmaceuticals, Inc.、Moleculin Biotech, Inc.较为活跃,换手率分别为810.36%、47.09%、31.06%,振幅较大的相关个股有Altamira Therapeutics Ltd.、Xtl生物制药、Ocugen, Inc.,振幅分别为21.97%、15.26%、8.53%。Nkarta, Inc.公司简介:Nkarta Inc 是一家生物制药公司,致力于开发用于治疗癌症的工程化自然杀伤 细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032521314387b3418e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032521314387b3418e&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2421845483","title":"BUZZ-Nkarta公司放弃血癌疗法开发后业绩下滑","url":"https://stock-news.laohu8.com/highlight/detail?id=2421845483","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2421845483?lang=zh_cn&edition=full","pubTime":"2024-03-22 23:34","pubTimestamp":1711121640,"startTime":"0","endTime":"0","summary":" 3月22日 - ** 疗法开发商Nkarta公司 股价下跌22.1%,至10.11美元 ** 该公司周四晚些时候公布的全年净亏损为1.175亿美元,去年同期为1.138亿美元* * 在一项早期研究显示部分患者的反应率明显降低后,该公司 表示已将其治疗一种血癌的疗法-- NKX101--置于 次要 地位 ** 公司将专注于推进自身免疫性疾病的治疗 ** 瑞穗证券将该公司的目标价从31美元下调至25美元,股票评级为 \"买入\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2421819973","title":"Nkarta, Inc.盘中异动 股价大跌26.81%","url":"https://stock-news.laohu8.com/highlight/detail?id=2421819973","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2421819973?lang=zh_cn&edition=full","pubTime":"2024-03-22 21:31","pubTimestamp":1711114281,"startTime":"0","endTime":"0","summary":"北京时间2024年03月22日21时31分,Nkarta, Inc.股票出现异动,股价大幅下挫26.81%。Nkarta, Inc.股票所在的生物技术行业中,整体涨幅为0.20%。其相关个股中,Gt Biopharma, Inc.、180 Life Sciences Corp C/Wts 07/11/2025、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 涨幅较大,Okyo Pharma Ltd Com Npv 、Revelation Biosciences, Inc.、Nutriband Inc.较为活跃,换手率分别为4.70%、3.52%、3.34%,振幅较大的相关个股有Jasper Therapeutics Inc C/Wts 24/09/2026 、Xtl生物制药、Nkarta, Inc.,振幅分别为32.68%、10.74%、9.40%。Nkarta, Inc.公司简介:Nkarta Inc 是一家生物制药公司,致力于开发用于治疗癌症的工程化自然杀伤 细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032221312187a7af9f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032221312187a7af9f&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2413421457","title":"Nkarta Inc盘中异动 早盘快速下挫5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2413421457","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2413421457?lang=zh_cn&edition=full","pubTime":"2024-02-21 22:49","pubTimestamp":1708526995,"startTime":"0","endTime":"0","summary":"北京时间2024年02月21日22时49分,Nkarta Inc股票出现波动,股价大幅跳水5.04%。Nkarta Inc股票所在的生物技术行业中,整体涨幅为0.10%。其相关个股中,Ventyx Biosciences Inc、Tc Biopharm Plc C/Wts 10/02/2028 、Ys Biopharma Co Ltd C/Wts 15/03/2028 涨幅较大,Kazia Therapeutics Limited、Kintara Therapeutics Inc、Ventyx Biosciences Inc较为活跃,换手率分别为60.22%、48.79%、47.95%,振幅较大的相关个股有Ventyx Biosciences Inc、Ys Biopharma Co Ltd C/Wts 15/03/2028 、Sab Biotherapeutics Inc C/Wts 22/10/2026 ,振幅分别为117.73%、58.57%、44.75%。Nkarta Inc公司简介:Nkarta Inc 是一家生物制药公司,致力于开发用于治疗癌症的工程化自然杀伤 细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402212249557a455f14&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402212249557a455f14&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.nkartatx.com","stockEarnings":[{"period":"1week","weight":-0.1333},{"period":"1month","weight":0.0721},{"period":"3month","weight":0.7822},{"period":"6month","weight":6.9748},{"period":"1year","weight":2.2412},{"period":"ytd","weight":0.6795}],"compareEarnings":[{"period":"1week","weight":0.0052},{"period":"1month","weight":0.034},{"period":"3month","weight":0.0975},{"period":"6month","weight":0.2238},{"period":"1year","weight":0.3225},{"period":"ytd","weight":0.1007}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Nkarta, Inc.于2015年7月在特拉华州成立。该公司是一家私人生物制药公司,致力于开发工程化的自然杀伤(NK)细胞来对抗癌症。该公司致力于利用NK细胞的天然强大功能来识别和杀死异常细胞,并募集适应性免疫效应子以产生特异性和持久性的反应。","yearOnYearQuotes":[{"month":1,"riseRate":0.25,"avgChangeRate":-0.112423},{"month":2,"riseRate":0.5,"avgChangeRate":0.066988},{"month":3,"riseRate":0.25,"avgChangeRate":-0.076581},{"month":4,"riseRate":0.666667,"avgChangeRate":0.327613},{"month":5,"riseRate":0,"avgChangeRate":-0.173203},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.123587},{"month":7,"riseRate":1,"avgChangeRate":0.048154},{"month":8,"riseRate":0.5,"avgChangeRate":-0.052154},{"month":9,"riseRate":0.25,"avgChangeRate":-0.049361},{"month":10,"riseRate":0.25,"avgChangeRate":-0.015611},{"month":11,"riseRate":0.75,"avgChangeRate":0.036387},{"month":12,"riseRate":0.5,"avgChangeRate":0.50486}],"exchange":"NASDAQ","name":"Nkarta","nameEN":"Nkarta"},"APP":{"userAgent":"claudebot","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.3","shortVersion":"4.22.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Nkarta(NKTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Nkarta(NKTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Nkarta,NKTX,Nkarta股票,Nkarta股票老虎,Nkarta股票老虎国际,Nkarta行情,Nkarta股票行情,Nkarta股价,Nkarta股市,Nkarta股票价格,Nkarta股票交易,Nkarta股票购买,Nkarta股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Nkarta(NKTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Nkarta(NKTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}